Dealing with Diabetes During Disasters – 2 slides per page
Dealing with Diabetes During Disasters – 6 slides per page
Insulin Handout
Dealing with Diabetes During Disasters.mp4 -Presentation This may take a few seconds to download to your computer
Handouts.pdf
Quiz.docx
In this knowledge-based continuing pharmacy education activity Stefanie Nigro, PharmD, BCACP, BC-ADM, CDE discusses the specific issues affecting those with diabetes during a disaster.
Target Audience:
Hospital and Community pharmacists and technicians who may be involved in a crisis situation.
Learning objectives:
At the conclusion of the activity, pharmacists will be able to:
|
|
|
At the conclusion of the activity pharmacy technicians will be able to:
|
|
|
Activity Faculty
Stefanie C. Nigro, Pharm.D., BCACP, BC-ADM, CDE
Associate Clinical Professor
University of Connecticut School of Pharmacy
Storrs, CT
Faculty Disclosure:
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
- Stefanie Nigro has no relationships with inelegible companies.
Program Fees:
The cost is $15.00.
Grant Funding:
This activity has no grant funding associated with it.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-20-069-H01-P/T) Credits will be electronically submitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: December 18, 2020
Planned expiration date: December 11, 2023
Disclaimer
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.